PL3357492T3 - Wielowarstwowa tabletka do podawania magnezu - Google Patents

Wielowarstwowa tabletka do podawania magnezu

Info

Publication number
PL3357492T3
PL3357492T3 PL18153151T PL18153151T PL3357492T3 PL 3357492 T3 PL3357492 T3 PL 3357492T3 PL 18153151 T PL18153151 T PL 18153151T PL 18153151 T PL18153151 T PL 18153151T PL 3357492 T3 PL3357492 T3 PL 3357492T3
Authority
PL
Poland
Prior art keywords
administration
magnesium
multilayer tablet
multilayer
tablet
Prior art date
Application number
PL18153151T
Other languages
English (en)
Inventor
Luciano Marcelloni
Umberto BENEGIAMO
Roberto Merico
Original Assignee
S.I.I.T. S.R.L.-Servizio Internazionale Imballaggi Termosaldanti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by S.I.I.T. S.R.L.-Servizio Internazionale Imballaggi Termosaldanti filed Critical S.I.I.T. S.R.L.-Servizio Internazionale Imballaggi Termosaldanti
Publication of PL3357492T3 publication Critical patent/PL3357492T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08Oxides; Hydroxides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL18153151T 2017-02-02 2018-01-24 Wielowarstwowa tabletka do podawania magnezu PL3357492T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT102017000011337A IT201700011337A1 (it) 2017-02-02 2017-02-02 Compressa multistrato per la somministrazione di magnesio
EP18153151.8A EP3357492B1 (en) 2017-02-02 2018-01-24 Multilayer tablet for administration of magnesium

Publications (1)

Publication Number Publication Date
PL3357492T3 true PL3357492T3 (pl) 2020-06-01

Family

ID=59031299

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18153151T PL3357492T3 (pl) 2017-02-02 2018-01-24 Wielowarstwowa tabletka do podawania magnezu

Country Status (10)

Country Link
EP (1) EP3357492B1 (pl)
ES (1) ES2770141T3 (pl)
HR (1) HRP20200188T1 (pl)
HU (1) HUE048002T2 (pl)
IT (1) IT201700011337A1 (pl)
PL (1) PL3357492T3 (pl)
PT (1) PT3357492T (pl)
RS (1) RS59864B1 (pl)
SI (1) SI3357492T1 (pl)
SM (1) SMT202000120T1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3459531B1 (de) * 2018-12-17 2020-10-28 Protina Pharmazeutische Gesellschaft mbH Verfahren zur herstellung einer schichttablette
CN120478295B (zh) * 2025-07-01 2025-11-21 仙乐健康科技股份有限公司 一种氧化镁双层缓释片及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4664915A (en) * 1981-07-01 1987-05-12 Bristol-Myers Company Compressed and formed alkaline component suitable for use in buffered aspirin product
GB0330009D0 (en) * 2003-12-24 2004-01-28 Ferrosan As Probiotic tablet formulations
EP1661575A1 (en) * 2004-11-26 2006-05-31 ZAMBON GROUP S.p.A. Use of magnesium in the treatment of disorders related to hormonal variations in women
FR2887455B1 (fr) * 2005-06-28 2007-08-10 Sanofi Aventis Sa Formulation a liberation prolongee de principes actifs de medicaments
US10485770B2 (en) * 2009-12-21 2019-11-26 Aptapharma, Inc. Functionally-coated multilayer tablets

Also Published As

Publication number Publication date
RS59864B1 (sr) 2020-03-31
HUE048002T2 (hu) 2020-05-28
IT201700011337A1 (it) 2018-08-02
EP3357492B1 (en) 2019-12-04
EP3357492A1 (en) 2018-08-08
HRP20200188T1 (hr) 2020-05-01
SMT202000120T1 (it) 2020-05-08
PT3357492T (pt) 2020-02-06
SI3357492T1 (sl) 2020-03-31
ES2770141T3 (es) 2020-06-30

Similar Documents

Publication Publication Date Title
IL254818A0 (en) Ribociclib tablet
EP3638658C0 (en) PHARMACEUTICAL COMPOUNDS
GB201704714D0 (en) Pharmaceutical compounds
GB201704965D0 (en) Pharmaceutical compounds
GB201703881D0 (en) Pharmaceutical compounds
SG10201914087UA (en) Tablet
GB201706806D0 (en) Pharmaceutical compounds
IL273704A (en) Pharmaceutical bilayer tablet formulations
GB201711704D0 (en) Pharmaceutical compounds
SMT202200092T1 (it) Composti farmaceutici
GB201704966D0 (en) Pharmaceutical compounds
PL3357492T3 (pl) Wielowarstwowa tabletka do podawania magnezu
IL249374A0 (en) Pharmaceutical administration forms
PL3290023T3 (pl) Kompozycja farmaceutyczna o przedłużonym uwalnianiu zawierająca rywastygminę
GB201511252D0 (en) Tablet
ZA201707549B (en) Extended release tablet comprising a weight-loss drug
PH32017000907S1 (en) Pharmaceutical tablets
AP00977S1 (en) Pharmaceutical tablets
AP00976S1 (en) Pharmaceutical tablets
AP00975S1 (en) Pharmaceutical tablets
GB201717005D0 (en) Pharmaceutical compounds
PH32014000079S1 (en) Pharmaceutical tablet
GB201700867D0 (en) Pharmaceutical compounds
TWM532873U (en) Tablet structure
GB201600998D0 (en) Fastened tablet stand